These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18946639)

  • 1. [Modern medical support for smoking cessation].
    Hering T
    Internist (Berl); 2009 Jan; 50(1):95-100. PubMed ID: 18946639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Medical therapy for smoking cessation].
    Zeller A
    Ther Umsch; 2010 Aug; 67(8):419-25. PubMed ID: 20687045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smoking cessation interventions: a primer for physicians: Comment on "Use of varenicline for 4 weeks before quitting smoking".
    Simon JA
    Arch Intern Med; 2011 Apr; 171(8):777-8. PubMed ID: 21518947
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current and future medical drugs for smoking cessation].
    Kusma B; Mache S; Deissenrieder F; Quarcoo D; Welte T; Groneberg D
    Laryngorhinootologie; 2009 Jun; 88(6):410-9; quiz 420-2. PubMed ID: 19504411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis.
    Mills EJ; Thorlund K; Eapen S; Wu P; Prochaska JJ
    Circulation; 2014 Jan; 129(1):28-41. PubMed ID: 24323793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smoking cessation therapy considerations for patients with chronic kidney disease.
    Manley HJ; Stack NM
    Nephrol Nurs J; 2008; 35(4):357-63, 394; quiz 364. PubMed ID: 18782998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparisons of high-dose and combination nicotine replacement therapy, varenicline, and bupropion for smoking cessation: a systematic review and multiple treatment meta-analysis.
    Mills EJ; Wu P; Lockhart I; Thorlund K; Puhan M; Ebbert JO
    Ann Med; 2012 Sep; 44(6):588-97. PubMed ID: 22860882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescribing of smoking cessation medication in England since the introduction of varenicline.
    Langley TE; Huang Y; McNeill A; Coleman T; Szatkowski L; Lewis S
    Addiction; 2011 Jul; 106(7):1319-24. PubMed ID: 21395894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking cessation-recent advances.
    McNeil JJ; Piccenna L; Ioannides-Demos LL
    Cardiovasc Drugs Ther; 2010 Aug; 24(4):359-67. PubMed ID: 20602163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Did the introduction of varenicline in England substitute for or add to the use of other smoking cessation medications?
    Kotz D; Fidler JA; West R
    Nicotine Tob Res; 2011 Sep; 13(9):793-9. PubMed ID: 21543548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of coadministration of varenicline, bupropion, and serotonin reuptake inhibitors in a smoking cessation program in the real-life setting.
    Issa JS; Abe TO; Moura S; Santos PC; Pereira AC
    Nicotine Tob Res; 2013 Jun; 15(6):1146-50. PubMed ID: 23128516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.
    Athanasakis K; Igoumenidis M; Karampli E; Vitsou E; Sykara G; Kyriopoulos J
    Clin Ther; 2012 Aug; 34(8):1803-14. PubMed ID: 22818870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost effectiveness of varenicline versus bupropion and unaided cessation for smoking cessation in a cohort of Finnish adult smokers.
    Linden K; Jormanainen V; Linna M; Sintonen H; Wilson K; Kotomäki T
    Curr Med Res Opin; 2010 Mar; 26(3):549-60. PubMed ID: 20050814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoting smoking cessation.
    Larzelere MM; Williams DE
    Am Fam Physician; 2012 Mar; 85(6):591-8. PubMed ID: 22534270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice.
    Aubin HJ; Luquiens A; Berlin I
    Br J Clin Pharmacol; 2014 Feb; 77(2):324-36. PubMed ID: 23488726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New findings on nicotine addiction and treatment.
    Rose JE
    Nebr Symp Motiv; 2009; 55():131-41. PubMed ID: 19013942
    [No Abstract]   [Full Text] [Related]  

  • 17. Characteristics of COPD smokers and effectiveness and safety of smoking cessation medications.
    Jiménez Ruiz CA; Ramos Pinedo A; Cicero Guerrero A; Mayayo Ulibarri M; Cristobal Fernández M; Lopez Gonzalez G
    Nicotine Tob Res; 2012 Sep; 14(9):1035-9. PubMed ID: 22345320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness analysis of varenicline versus existing smoking cessation strategies in Central America and the Caribbean using the BENESCO model.
    Lutz MA; Lovato P; Cuesta G
    Hosp Pract (1995); 2012 Feb; 40(1):24-34. PubMed ID: 22406880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua.
    Lutz MA; Lovato P; Cuesta G
    Hosp Pract (1995); 2012 Feb; 40(1):35-43. PubMed ID: 22406881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smoking cessation treatment for COPD smokers: the role of pharmacological interventions.
    Jiménez-Ruiz CA; Fagerström KO
    Monaldi Arch Chest Dis; 2013 Mar; 79(1):27-32. PubMed ID: 23741943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.